Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cells|April 3, 2021
Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular DiseasesAnna Wolska, Mart Reimund, Denis O Sviridov, et al.
Atherosclerosis|November 4, 2017
Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolismAnna Wolska, Richard L Dunbar, Lita A Freeman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2012
Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporterDenis O Sviridov, Alexander M Andrianov, Ivan V Anishchenko, et al.
Biochemical and Biophysical Research Communications|March 31, 2020
Incorporation of α-methylated amino acids into Apolipoprotein A-I mimetic peptides improves their helicity and cholesterol efflux potentialRafique Islam, Denis O Sviridov, Steven K Drake, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 22, 2022
Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivoWenmin Yuan, Kelsey Ernst, Rui Kuai, et al.
International Journal of Molecular Sciences|October 14, 2022
A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross LinkingKianoush Jeiran, Scott M Gordon, Denis O Sviridov, et al.
Journal of Lipid Research|June 29, 2015
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesAnna Schwendeman, Denis O Sviridov, Wenmin Yuan, et al.
Journal of Virology|January 4, 2024
Hepatitis C virus E1 recruits high-density lipoprotein to support infectivity and evade antibody recognitionJennifer Casiano Matos, Kaneemozhe Harichandran, Jingrong Tang, et al.
Science Translational Medicine|January 31, 2020
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglyceridesAnna Wolska, Larry Lo, Denis O Sviridov, et al.
Blood Advances|October 11, 2022
Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activityTony J Zheng, Tia C L Kohs, Paul A Mueller, et al.
Pageof 1